# A Phase I Trial of DM-CHOC-PEN in Adolescent and Young Adult (AYA) Subjects With Advanced Cancers

> **NCT02889445** · — · NO_LONGER_AVAILABLE · sponsor: **DEKK-TEC, Inc.**

## Conditions studied

- Advanced Cancer

## Interventions

- **DRUG:** 4-Demethyl-4-cholesteryloxycarbonylpenclomedine

## Key facts

- **NCT ID:** NCT02889445
- **Lead sponsor:** DEKK-TEC, Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** EXPANDED_ACCESS
- **Status:** NO_LONGER_AVAILABLE
- **Start date:** —
- **Primary completion:** —
- **Final completion:** —
- **Target enrollment:** — (—)
- **Last updated:** 2020-08-18


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02889445

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02889445, "A Phase I Trial of DM-CHOC-PEN in Adolescent and Young Adult (AYA) Subjects With Advanced Cancers". Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/clinical/NCT02889445. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*